Production & Innovation Demography, health systems & work

Weight-loss drugs

GLP-1 medicines are reaching tens of millions of patients as prices fall and pills arrive, and are expanding into heart, kidney and addiction uses, reshaping pharmaceutical revenues, food demand and obesity care economics.

Rank: 50; of 250 trends
Attention intensity: 2.0×; 1× is the typical trend
Attention index: 201; 100 is the typical trend
Change: −1%; WoW
Volatility: ±4%; Shifting

The week ending 7 Nov 2026, World. Volatility is the typical weekly move over the last 26 weeks. How these are measured.

Regional Attention

By region

Latin America & Caribbean

Europe

East Asia

7.8×

#30

6.7×

#37

6.1×

#38

5.6×

#37

4.8×

#50

2.1×

#82

1.5×

#126

1.2×

#144

0.67×

#182

0.60×

#195

This trend’s attention intensity in each region, and its rank among the 250 trends there: the 10 highest of 11.

By bloc

5.4×

#40

4.9×

#36

4.4×

#51

4.2×

#43

2.9×

#55

2.5×

#56

2.4×

#50

2.1×

#82

2.1×

#88

1.9×

#89

This trend’s attention intensity in each bloc, the average of its member countries, and its rank there: the 10 highest of 13.

By country

34×

#19

14×

#19

12×

#31

11×

#18

9.9×

#33

9.3×

#36

8.8×

#34

7.6×

#44

7.4×

#50

7.0×

#40

This trend’s attention intensity in each country, and its rank among the 250 trends there: the 10 highest of 49.

Attention Index over time

The attention index, worldwide and in each region: 100 is the typical trend in each place, the median of every trend's attention there over the past 52 weeks.

Attention to Weight-loss drugs, by place

Attention index, a four-week rolling average, on a log scale. 100 is the typical trend in each place, so a line at 1,000 is ten times the typical trend’s attention there. A country chosen at the top of the page is drawn beside its region and the world. Select a place below to bring its line forward.